Buy or sell Calysta Energy stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Calysta Energy Stock

Calysta Energy develops a new biological gas-to-liquids™ (BioGTL™) and biological gas-to-chemicals (BioGTC™) technology using natural gas.

About Calysta Energy Stock

Calysta Energy (www.calystaenergy.com), Menlo Park, CA., is developing a new biological gas-to-liquids™ (BioGTL™) and biological gas-to-chemicals (BioGTC™) technology using methane – an energy-rich component of natural gas – as a new sustainable biological feedstock for high value industrial chemicals and transportation fuels with cost and performance advantages over current processes. The company is a spinout of DNA2.0, the largest US-based provider of synthetic genes for industrial and academic use.

Funding History

May 2011$5.0M
December 2013$3.0M
January 2015$10.0M
February 2016$30.0M
May 2017$40.0M

Management

Chief Financial Officer and Chief Sustainability Officer

Lynsey Wenger

Vice President, Biological Engineering

Lori Giver

Co-founder

David McElroy

President and Chief Executive Officer

Alan Shaw

Vice President, Global Capital Projects

Graham Aylen

Chief Product and Innovation Officer

Josh Silverman

Vice President, Business Development

Dennis Leong

Vice President, Nutrition

Arild Johannessen

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Calysta Energy or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo